CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
-2.22%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$1.07B
AUM Growth
+$1.07B
(+0.55%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
5.91%
Top 10 Holdings %
Top 10 Hldgs %
36.46%
Holding
509
New
13
Increased
172
Reduced
270
Closed
23
Top Buys
| 1 |
Apple
AAPL
|
$12.2M |
| 2 |
Amazon
AMZN
|
$8.41M |
| 3 |
Microsoft
MSFT
|
$6.53M |
| 4 |
Analog Devices
ADI
|
$4.63M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$3.68M |
Top Sells
| 1 |
iShares Silver Trust
SLV
|
$7.9M |
| 2 |
ProShares Ultra Gold
UGL
|
$7.89M |
| 3 |
Arista Networks
ANET
|
$6.7M |
| 4 |
Gilead Sciences
GILD
|
$5.26M |
| 5 |
TSMC
TSM
|
$3.61M |
Sector Composition
| 1 | Technology | 36.93% |
| 2 | Healthcare | 24.36% |
| 3 | Consumer Discretionary | 11.82% |
| 4 | Communication Services | 11.17% |
| 5 | Consumer Staples | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Amer Sports
AS
$21B
| $3M | 0.28% |
112,301
-23,269
| -17% | -$622K |
|
77
Autodesk
ADSK
$67.9B
| $2.93M | 0.27% |
11,210
+3,111
| +38% | +$814K |
|
78
Applied Materials
AMAT
$124B
| $2.91M | 0.27% |
20,067
+6,651
| +50% | +$965K |
|
79
Exxon Mobil
XOM
$477B
| $2.91M | 0.27% |
24,428
+2,431
| +11% | +$289K |
|
80
Walmart
WMT
$793B
| $2.88M | 0.27% |
32,713
-10,825
| -25% | -$953K |
|
81
Summit Therapeutics
SMMT
$17.5B
| $2.85M | 0.27% |
147,966
-8,400
| -5% | -$162K |
|
|
ITCI
82
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.81M | 0.26% |
21,328
-1,152
| -5% | -$152K |
|
83
United Therapeutics
UTHR
$17.7B
| $2.78M | 0.26% |
9,009
-457
| -5% | -$141K |
|
84
Insmed
INSM
$30.3B
| $2.77M | 0.26% |
36,305
-1,629
| -4% | -$124K |
|
85
Starbucks
SBUX
$99.2B
| $2.76M | 0.26% |
28,152
+9,604
| +52% | +$942K |
|
86
Trip.com Group
TCOM
$46.6B
| $2.75M | 0.26% |
43,000
-9,830
| -19% | -$628K |
|
87
BioMarin Pharmaceuticals
BMRN
$11.3B
| $2.73M | 0.25% |
38,640
-2,144
| -5% | -$152K |
|
88
Royalty Pharma
RPRX
$15.8B
| $2.71M | 0.25% |
86,918
-7,290
| -8% | -$227K |
|
89
CVS Health
CVS
$93B
| $2.57M | 0.24% |
+37,871
| New | +$2.57M |
|
|
VNET
90
VNET Group
VNET
$2.15B
| $2.46M | 0.23% |
+300,000
| New | +$2.46M |
|
91
Mercado Libre
MELI
$120B
| $2.44M | 0.23% |
1,252
+427
| +52% | +$833K |
|
92
Intel
INTC
$105B
| $2.43M | 0.23% |
106,947
+36,757
| +52% | +$835K |
|
93
Micron Technology
MU
$133B
| $2.39M | 0.22% |
27,519
+9,389
| +52% | +$817K |
|
94
Incyte
INCY
$17B
| $2.35M | 0.22% |
38,818
-2,031
| -5% | -$123K |
|
95
Atlassian
TEAM
$44.8B
| $2.32M | 0.22% |
10,950
+1,822
| +20% | +$387K |
|
|
ONC
96
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $2.28M | 0.21% |
8,394
-1,009
| -11% | -$275K |
|
97
Moderna
MRNA
$9.36B
| $2.22M | 0.21% |
78,191
-4,208
| -5% | -$119K |
|
98
Neurocrine Biosciences
NBIX
$13.5B
| $2.21M | 0.21% |
19,999
-1,469
| -7% | -$162K |
|
99
Alibaba
BABA
$325B
| $2.2M | 0.2% |
+16,619
| New | +$2.2M |
|
100
Mondelez International
MDLZ
$79.3B
| $2.18M | 0.2% |
31,949
+10,187
| +47% | +$695K |
|